Serge Goldner
Directeur Général chez CORETECH 5
Profil
Serge Goldner was the founder of Cukierman & Co. Life Sciences, founded in 2006, where he held the title of Managing Partner.
He is also the founder of Coretech 5 SA, founded in 2014, where he currently holds the titles of Chairman & Chief Executive Officer.
Mr. Goldner's former job was as Chief Financial Officer at Immune Pharmaceuticals, Inc.
Postes actifs de Serge Goldner
Sociétés | Poste | Début |
---|---|---|
CORETECH 5 | Directeur Général | 14/07/2014 |
Anciens postes connus de Serge Goldner
Sociétés | Poste | Fin |
---|---|---|
Cukierman & Co. Life Sciences
Cukierman & Co. Life Sciences Investment Banks/BrokersFinance Cukierman & Co. Life Sciences engages in the provision of investment banking services to private and public companies in the fields of biotechnology, pharmaceuticals, diagnostics, medical services, and digital health. The company was founded on 2006 and is headquartered in Tel Aviv, Israel. | Fondateur | - |
IMMUNE PHARMACEUTICALS, INC. | Directeur Financier/CFO | - |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
CORETECH 5 | Process Industries |
Entreprise privées | 2 |
---|---|
Immune Pharmaceuticals, Inc.
Immune Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Immune Pharmaceuticals, Inc. is a biopharmaceutical company developing novel therapeutic agents for the treatment of immunologic and inflammatory diseases. Its lead product, Bertilimumab, is a human monoclonal antibody that binds eotaxin-1, a chemokine that attracts eosinophils to the site of inflammation. Bertilimumab has shown promising clinical activity in bullous pemphigoid and has been studied in other conditions including allergic rhinitis and ulcerative colitis, and may have application in other diseases, including atopic dermatitis, asthma, and other diseases. It is also developing NanoCyclo, a topical nano-encapsulated formulation of cyclosporine, for the treatment of atopic dermatitis (AD) and psoriasis. The company was founded by Daniel Gedeon Teper on March 9, 1993 and is headquartered in Englewood Cliffs, NJ. | Health Technology |
Cukierman & Co. Life Sciences
Cukierman & Co. Life Sciences Investment Banks/BrokersFinance Cukierman & Co. Life Sciences engages in the provision of investment banking services to private and public companies in the fields of biotechnology, pharmaceuticals, diagnostics, medical services, and digital health. The company was founded on 2006 and is headquartered in Tel Aviv, Israel. | Finance |